As of 2024-12-14, the EV/EBITDA ratio of Inhibrx Inc (INBX) is -0.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INBX's latest enterprise value is 15.37 mil USD. INBX's TTM EBITDA according to its financial statements is -368.06 mil USD. Dividing these 2 quantities gives us the above INBX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 16.8x | 15.9x |
| Forward P/E multiples | 15.2x - 21.1x | 15.5x |
| Fair Price | (372.80) - (413.47) | (385.51) |
| Upside | -2649.9% - -2928.1% | -2736.8% |
| Date | EV/EBITDA |
| 2024-12-11 | -0.06 |
| 2024-12-10 | -0.06 |
| 2024-12-09 | -0.05 |
| 2024-12-06 | -0.08 |
| 2024-12-05 | -0.06 |
| 2024-12-04 | -0.06 |
| 2024-12-03 | -0.06 |
| 2024-12-02 | -0.06 |
| 2024-11-29 | -0.07 |
| 2024-11-27 | -0.08 |
| 2024-11-26 | -0.07 |
| 2024-11-25 | -0.05 |
| 2024-11-22 | -0.02 |
| 2024-11-21 | -0.02 |
| 2024-11-20 | -0.02 |
| 2024-11-19 | -0.03 |
| 2024-11-18 | -0.00 |
| 2024-11-15 | -0.01 |
| 2024-11-14 | -0.03 |
| 2024-11-13 | -0.07 |
| 2024-11-12 | -0.12 |
| 2024-11-11 | -0.10 |
| 2024-11-08 | -0.10 |
| 2024-11-07 | -0.11 |
| 2024-11-06 | -0.10 |
| 2024-11-05 | -0.08 |
| 2024-11-04 | -0.08 |
| 2024-11-01 | -0.09 |
| 2024-10-31 | -0.10 |
| 2024-10-30 | -0.11 |
| 2024-10-29 | -0.10 |
| 2024-10-28 | -0.10 |
| 2024-10-25 | -0.07 |
| 2024-10-24 | -0.07 |
| 2024-10-23 | -0.09 |
| 2024-10-22 | -0.09 |
| 2024-10-21 | -0.08 |
| 2024-10-18 | -0.10 |
| 2024-10-17 | -0.10 |
| 2024-10-16 | -0.10 |
| 2024-10-15 | -0.09 |
| 2024-10-14 | -0.08 |
| 2024-10-11 | -0.08 |
| 2024-10-10 | -0.08 |
| 2024-10-09 | -0.08 |
| 2024-10-08 | -0.10 |
| 2024-10-07 | -0.07 |
| 2024-10-04 | -0.05 |
| 2024-10-03 | -0.05 |
| 2024-10-02 | -0.07 |